Published in Immunotherapy Weekly, May 18th, 2005
Records indicate that Decapinol is the first new chemical entity approved to help prevent and treat gingivitis in the past 30 years.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.